Asaf Danziger, Chief Executive Officer at NovoCure Ltd (NVCR), sold 22,709 shares at $54.64 ($1.3M) on 2019-03-04, disclosed to the SEC on 2019-03-06.
Open-market sale of $1.3M NVCR by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $54.64 | 3,700 | $202K | 15.9% |
| 2 | $56.00 | 6,127 | $343K | 26.9% |
| 3 | $56.51 | 6,441 | $364K | 28.6% |
| 4 | $56.51 | 6,441 | $364K | 28.6% |
| Total | $56.07 avg | 22,709 | $1.3M | 100% |
| Filing → |
| NVCR | SELL | 2021-04-15 | $38.5M | — | Filing → |
| NVCR | SELL | 2020-12-22 | $61.4M | — | Filing → |
| NVCR | SELL | 2020-09-17 | $10.2M | — | Filing → |